Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Futibatinib by Otsuka Pharmaceutical for Endometrial Cancer: Likelihood of Approval
Futibatinib is under clinical development by Otsuka Pharmaceutical and currently in Phase II for Endometrial Cancer. According to GlobalData, Phase...
Futibatinib by Otsuka Pharmaceutical for Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer): Likelihood of Approval
Futibatinib is under clinical development by Otsuka Pharmaceutical and currently in Phase II for Human Epidermal Growth Factor Receptor 2...
Futibatinib by Otsuka Pharmaceutical for Metastatic Breast Cancer: Likelihood of Approval
Futibatinib is under clinical development by Otsuka Pharmaceutical and currently in Phase II for Metastatic Breast Cancer. According to GlobalData,...
Futibatinib by Otsuka Pharmaceutical for Gastric Cancer: Likelihood of Approval
Futibatinib is under clinical development by Otsuka Pharmaceutical and currently in Phase II for Gastric Cancer. According to GlobalData, Phase...
Futibatinib by Otsuka Pharmaceutical for Pancreatic Ductal Adenocarcinoma: Likelihood of Approval
Futibatinib is under clinical development by Otsuka Pharmaceutical and currently in Phase II for Pancreatic Ductal Adenocarcinoma. According to GlobalData,...
Futibatinib by Otsuka Pharmaceutical for Solid Tumor: Likelihood of Approval
Futibatinib is under clinical development by Otsuka Pharmaceutical and currently in Phase II for Solid Tumor. According to GlobalData, Phase...
Futibatinib by Otsuka Pharmaceutical for Esophageal Squamous Cell Carcinoma (ESCC): Likelihood of Approval
Futibatinib is under clinical development by Otsuka Pharmaceutical and currently in Phase II for Esophageal Squamous Cell Carcinoma (ESCC). According...
Futibatinib by Otsuka Pharmaceutical for Transitional Cell Carcinoma (Urothelial Cell Carcinoma): Likelihood of Approval
Futibatinib is under clinical development by Otsuka Pharmaceutical and currently in Phase II for Transitional Cell Carcinoma (Urothelial Cell Carcinoma)....